Viable myocardium: how much is enough?

Area of Science:

• Cardiology
• Medical Imaging

Background:

• Left ventricular systolic dysfunction often stems from coronary artery disease (CAD).
• Chronic hypoperfusion in CAD alters cardiac myocyte metabolism, creating a perfusion-contraction mismatch where function is compromised for survival.
• Timely revascularization can restore metabolism and cardiac function.

Purpose of the Study:

• To review the significance of myocardial viability assessment in guiding revascularization decisions.
• To determine the extent of viable myocardium necessary to warrant revascularization.
• To highlight the link between improved myocardial function and reduced morbidity/mortality from heart failure and arrhythmias.

Main Methods:

• Review of noninvasive imaging modalities for assessing myocardial viability.
• Discussion of nuclear imaging techniques (e.g., thallium-201 SPECT, PET) and their sensitivity/specificity.
• Evaluation of dobutamine stress echocardiogram (DSE) and contrast-enhanced MRI for viability assessment.

Main Results:

• Noninvasive imaging effectively identifies myocardial viability, aiding patient selection for revascularization.
• Nuclear imaging offers high sensitivity but lower specificity; DSE has lower sensitivity but better specificity.
• Contrast-enhanced MRI is emerging as a sensitive and specific tool for viability assessment.

Conclusions:

• Accurate assessment of myocardial viability is crucial for optimizing revascularization strategies in CAD patients.
• Identifying viable myocardium guides treatment, potentially improving outcomes and reducing heart failure complications.
• Improved cardiac function post-revascularization correlates with decreased morbidity and mortality.